
VarmX, a biotechnology company based at the Leiden Bio Science Park (LBSP), has entered into a strategic collaboration and option agreement with global biotechnology leader CSL Limited (ASX:CSL) to advance its lead asset, VMX-C001. The investigational therapy is designed to…










